NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Dr. Kevin O’Mara announced this week he will step down as dean of the Lundy-Fetterman School of Business at Campbell… More on this postRead More